Search for COVID19 targets
You are searching for: COVID-19
T94549 Target Info |
Target Name | HUMAN angiopoietin-2 (ANG-2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | LY3127804 | Drug Info |
T94912 Target Info |
Target Name | HUMAN C5a receptor (C5aR) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Avdoralimab | Drug Info |
T97747 Target Info |
Target Name | HUMAN C-C chemokine receptor 5 (CCR5) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Leronlimab | Drug Info |
T90070 Target Info |
Target Name | HUMAN interleukin 8 (IL8) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | BMS-986253 | Drug Info |
T94119 Target Info |
Target Name | HUMAN PI3-kinase delta (PIK3CD) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Duvelisib | Drug Info |
T94131 Target Info |
Target Name | HUMAN PI3-kinase gamma (PIK3CG) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Duvelisib | Drug Info |
T89083 Target Info |
Target Name | HUMAN toll-like receptor 2 (TLR2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | PUL-042 | Drug Info |
T89415 Target Info |
Target Name | HUMAN toll-like receptor 6 (TLR6) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | PUL-042 | Drug Info |
T87633 Target Info |
Target Name | HUMAN toll-like receptor 9 (TLR9) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | PUL-042 | Drug Info |
T99685 Target Info |
Target Name | HUMAN mammalian target of rapamycin (mTOR) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Sirolimus | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.